Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholders.

Wasir R, Irawati S, Makady A, Postma M, Goettsch W, Feenstra T, Buskens E.

PLoS One. 2019 Nov 27;14(11):e0225626. doi: 10.1371/journal.pone.0225626. eCollection 2019.

2.

Cost-Effectiveness of Treatments in Children With Attention-Deficit/Hyperactivity Disorder: A Continuous-Time Markov Modeling Approach.

Freriks RD, Mierau JO, van der Schans J, Groenman AP, Hoekstra PJ, Postma MJ, Buskens E, Cao Q.

MDM Policy Pract. 2019 Aug 17;4(2):2381468319867629. doi: 10.1177/2381468319867629. eCollection 2019 Jul-Dec.

3.

Personal and Societal Impact of Low Back Pain: The Groningen Spine Cohort.

Dutmer AL, Schiphorst Preuper HR, Soer R, Brouwer S, Bültmann U, Dijkstra PU, Coppes MH, Stegeman P, Buskens E, van Asselt ADI, Wolff AP, Reneman MF.

Spine (Phila Pa 1976). 2019 Dec 15;44(24):E1443-E1451. doi: 10.1097/BRS.0000000000003174.

PMID:
31369481
4.

Health-related quality of life and well-being health state values among Dutch oldest old.

Botes R, Vermeulen KM, Gerber AM, Ranchor AV, Buskens E.

Patient Prefer Adherence. 2019 May 7;13:721-728. doi: 10.2147/PPA.S193171. eCollection 2019.

5.

Neighborhood Socioeconomic Status and Health Care Costs: A Population-Wide Study in the Netherlands.

de Boer WIJ, Buskens E, Koning RH, Mierau JO.

Am J Public Health. 2019 Jun;109(6):927-933. doi: 10.2105/AJPH.2019.305035. Epub 2019 Apr 18.

PMID:
30998412
6.

Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia.

Wasir R, Irawati S, Makady A, Postma M, Goettsch W, Buskens E, Feenstra T.

PLoS One. 2019 Feb 19;14(2):e0212328. doi: 10.1371/journal.pone.0212328. eCollection 2019.

7.

Cost-effectiveness, cost-utility and the budget impact of antidepressants versus preventive cognitive therapy with or without tapering of antidepressants.

Klein NS, Wijnen BFM, Lokkerbol J, Buskens E, Elgersma HJ, van Rijsbergen GD, Slofstra C, Ormel J, Dekker J, de Jong PJ, Nolen WA, Schene AH, Hollon SD, Burger H, Bockting CLH.

BJPsych Open. 2019 Jan;5(1):e12. doi: 10.1192/bjo.2018.81.

8.

Functioning and quality of life in Dutch oldest old with diverse levels of dependency.

Botes R, Vermeulen KM, Gerber AM, Ranchor AV, Buskens E.

Patient Prefer Adherence. 2018 Oct 16;12:2187-2196. doi: 10.2147/PPA.S175388. eCollection 2018.

9.

Superiority of Step-up Approach vs Open Necrosectomy in Long-term Follow-up of Patients With Necrotizing Pancreatitis.

Hollemans RA, Bakker OJ, Boermeester MA, Bollen TL, Bosscha K, Bruno MJ, Buskens E, Dejong CH, van Duijvendijk P, van Eijck CH, Fockens P, van Goor H, van Grevenstein WM, van der Harst E, Heisterkamp J, Hesselink EJ, Hofker S, Houdijk AP, Karsten T, Kruyt PM, van Laarhoven CJ, Laméris JS, van Leeuwen MS, Manusama ER, Molenaar IQ, Nieuwenhuijs VB, van Ramshorst B, Roos D, Rosman C, Schaapherder AF, van der Schelling GP, Timmer R, Verdonk RC, de Wit RJ, Gooszen HG, Besselink MG, van Santvoort HC; Dutch Pancreatitis Study Group.

Gastroenterology. 2019 Mar;156(4):1016-1026. doi: 10.1053/j.gastro.2018.10.045. Epub 2018 Nov 2.

PMID:
30391468
10.

Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration.

Cao Q, Buskens E, Hillege HL, Jaarsma T, Postma M, Postmus D.

Eur J Health Econ. 2019 Apr;20(3):475-482. doi: 10.1007/s10198-018-1013-z. Epub 2018 Oct 29.

11.

A Scoping Review of Key Health Items in Self-Report Instruments Used Among Solid Organ Transplant Recipients.

Shahabeddin Parizi A, Krabbe PFM, Buskens E, Bakker SJL, Vermeulen KM.

Patient. 2019 Apr;12(2):171-181. doi: 10.1007/s40271-018-0335-3. Review.

12.

The cost-utility of stepped-care algorithms according to depression guideline recommendations - Results of a state-transition model analysis.

Meeuwissen JAC, Feenstra TL, Smit F, Blankers M, Spijker J, Bockting CLH, van Balkom AJLM, Buskens E.

J Affect Disord. 2019 Jan 1;242:244-254. doi: 10.1016/j.jad.2018.08.024. Epub 2018 Aug 9.

PMID:
30216769
13.

The early economic evaluation of novel biomarkers to accelerate their translation into clinical applications.

de Graaf G, Postmus D, Westerink J, Buskens E.

Cost Eff Resour Alloc. 2018 Jun 18;16:23. doi: 10.1186/s12962-018-0105-z. eCollection 2018.

14.

Long-term incidence and risk factors of cardiovascular events in Asian populations: systematic review and meta-analysis of population-based cohort studies.

Irawati S, Wasir R, Floriaan Schmidt A, Islam A, Feenstra T, Buskens E, Wilffert B, Hak E.

Curr Med Res Opin. 2019 Feb;35(2):291-299. doi: 10.1080/03007995.2018.1491149. Epub 2018 Jul 30.

PMID:
29920124
15.

Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: a cost-effectiveness study.

Koleva-Kolarova RG, Greuter MJW, Feenstra TL, Vermeulen KM, de Vries EFJ, Parkin D, Buskens E, de Bock GH.

Oncotarget. 2018 Apr 13;9(28):19836-19846. doi: 10.18632/oncotarget.24869. eCollection 2018 Apr 13.

16.

Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial.

Bockting CLH, Klein NS, Elgersma HJ, van Rijsbergen GD, Slofstra C, Ormel J, Buskens E, Dekker J, de Jong PJ, Nolen WA, Schene AH, Hollon SD, Burger H.

Lancet Psychiatry. 2018 May;5(5):401-410. doi: 10.1016/S2215-0366(18)30100-7. Epub 2018 Apr 3.

PMID:
29625762
17.

Head-to-Head Comparison of EQ-5D-3L and EQ-5D-5L Health Values.

Selivanova A, Buskens E, Krabbe PFM.

Pharmacoeconomics. 2018 Jun;36(6):715-725. doi: 10.1007/s40273-018-0647-0.

18.

Functional health state description and valuation by people aged 65 and over: a pilot study.

Botes R, Vermeulen KM, Ranchor AV, Buskens E.

BMC Geriatr. 2018 Jan 16;18(1):11. doi: 10.1186/s12877-018-0711-9.

19.

Relative contribution of various chronic diseases and multi-morbidity to potential disability among Dutch elderly.

Botes R, Vermeulen KM, Correia J, Buskens E, Janssen F.

BMC Health Serv Res. 2018 Jan 15;18(1):24. doi: 10.1186/s12913-017-2820-0.

20.

Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator.

van Barreveld M, Dijkgraaf MGW, Hulleman M, Boersma LVA, Delnoy PPHM, Meine M, Tuinenburg AE, Theuns DAMJ, van der Voort PH, Kimman GP, Buskens E, Tijssen JPG, Bruinsma N, Verstraelen TE, Zwinderman AH, van Dessel PHFM, Wilde AAM; DO-IT investigators.

Neth Heart J. 2017 Oct;25(10):574-580. doi: 10.1007/s12471-017-1016-x.

21.

Early health technology assessment of magnetic resonance-guided high intensity focused ultrasound ablation for the treatment of early-stage breast cancer.

Knuttel FM, Huijsse SEM, Feenstra TL, Moonen CTW, van den Bosch MAAJ, Buskens E, Greuter MJW, de Bock GH.

J Ther Ultrasound. 2017 Aug 1;5:23. doi: 10.1186/s40349-017-0101-3. eCollection 2017.

22.

Serious child and adolescent behaviour disorders; a valuation study by professionals, youth and parents.

Vermeulen KM, Jansen DEMC, Buskens E, Knorth EJ, Reijneveld SA.

BMC Psychiatry. 2017 Jun 2;17(1):208. doi: 10.1186/s12888-017-1363-6.

23.

Increased life expectancy as a result of non-hormonal targeted therapies for HER2 or hormone receptor positive metastatic breast cancer: A systematic review and meta-analysis.

Koleva-Kolarova RG, Oktora MP, Robijn AL, Greuter MJW, Reyners AKL, Buskens E, de Bock GH.

Cancer Treat Rev. 2017 Apr;55:16-25. doi: 10.1016/j.ctrv.2017.01.001. Epub 2017 Feb 20. Review.

PMID:
28288388
24.

Cost-effectiveness of multisystemic therapy versus usual treatment for young people with antisocial problems: a reply to McIntosh.

Vermeulen KM, Jansen DE, Knorth EJ, Buskens E, Reijneveld SA.

Crim Behav Ment Health. 2017 Feb;27(1):103-104. doi: 10.1002/cbm.2022. No abstract available.

PMID:
28176428
25.

Centralising and optimising decentralised stroke care systems: a simulation study on short-term costs and effects.

Lahr MM, van der Zee DJ, Luijckx GJ, Vroomen PC, Buskens E.

BMC Med Res Methodol. 2017 Jan 10;17(1):5. doi: 10.1186/s12874-016-0275-3.

26.

Simulation modelling to assess prehospital thrombolysis.

Lahr MMH, van der Zee DJ, Luijckx GJ, Uyttenboogaart M, Buskens E.

Lancet Neurol. 2016 Dec;15(13):1305-1306. doi: 10.1016/S1474-4422(16)30288-5. No abstract available.

PMID:
27839643
27.

A cohort study of elderly people in Bloemfontein, South Africa, to determine health-related quality of life and functional abilities.

Gerber AM, Botes R, Mostert A, Vorster A, Buskens E.

S Afr Med J. 2016 Feb 4;106(3):298-301. doi: 10.7196/SAMJ.2016.v106i3.10171.

PMID:
26915946
28.

Cost-effectiveness of multisystemic therapy versus usual treatment for young people with antisocial problems.

Vermeulen KM, Jansen DE, Knorth EJ, Buskens E, Reijneveld SA.

Crim Behav Ment Health. 2017 Feb;27(1):89-102. doi: 10.1002/cbm.1988. Epub 2016 Jan 15.

PMID:
26767941
29.

Predictive validity of a frailty measure (GFI) and a case complexity measure (IM-E-SA) on healthcare costs in an elderly population.

Peters LL, Burgerhof JG, Boter H, Wild B, Buskens E, Slaets JP.

J Psychosom Res. 2015 Nov;79(5):404-11. doi: 10.1016/j.jpsychores.2015.09.015. Epub 2015 Oct 5.

PMID:
26526316
30.

Using multicriteria decision analysis to support research priority setting in biomedical translational research projects.

de Graaf G, Postmus D, Buskens E.

Biomed Res Int. 2015;2015:191809. doi: 10.1155/2015/191809. Epub 2015 Oct 1.

31.

Increased Intake of Foods with High Nutrient Density Can Help to Break the Intergenerational Cycle of Malnutrition and Obesity.

Troesch B, Biesalski HK, Bos R, Buskens E, Calder PC, Saris WH, Spieldenner J, Verkade HJ, Weber P, Eggersdorfer M.

Nutrients. 2015 Jul 21;7(7):6016-37. doi: 10.3390/nu7075266. Review.

32.

Continuous-Time Semi-Markov Models in Health Economic Decision Making: An Illustrative Example in Heart Failure Disease Management.

Cao Q, Buskens E, Feenstra T, Jaarsma T, Hillege H, Postmus D.

Med Decis Making. 2016 Jan;36(1):59-71. doi: 10.1177/0272989X15593080. Epub 2015 Jul 14.

33.

Design of stepwise screening for prediabetes and type 2 diabetes based on costs and cases detected.

de Graaf G, Postmus D, Bakker SJ, Buskens E.

J Clin Epidemiol. 2015 Sep;68(9):1010-8. doi: 10.1016/j.jclinepi.2015.05.019. Epub 2015 May 27.

PMID:
26142919
34.

Do individuals with and without depression value depression differently? And if so, why?

Papageorgiou K, Vermeulen KM, Schroevers MJ, Stiggelbout AM, Buskens E, Krabbe PF, van den Heuvel E, Ranchor AV.

Qual Life Res. 2015 Nov;24(11):2565-75. doi: 10.1007/s11136-015-1018-3. Epub 2015 Jun 3.

35.

Construct validity of the Groningen Frailty Indicator established in a large sample of home-dwelling elderly persons: Evidence of stability across age and gender.

Peters LL, Boter H, Burgerhof JG, Slaets JP, Buskens E.

Exp Gerontol. 2015 Sep;69:129-41. doi: 10.1016/j.exger.2015.05.006. Epub 2015 May 15.

PMID:
25981741
36.

The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients.

Koleva-Kolarova RG, Greuter MJ, van Kruchten M, Vermeulen KM, Feenstra T, Buskens E, Glaudemans AW, de Vries EF, de Vries EG, Hospers GA, de Bock GH.

Br J Cancer. 2015 May 12;112(10):1617-25. doi: 10.1038/bjc.2015.138. Epub 2015 Apr 16.

37.

Evaluation of patient registries supporting reimbursement decisions: the case of oxaliplatin for treatment of stage III colon cancer.

Mohseninejad L, van Gils C, Uyl-de Groot CA, Buskens E, Feenstra T.

Value Health. 2015 Jan;18(1):84-90. doi: 10.1016/j.jval.2014.10.008.

38.

Selected nutrients and their implications for health and disease across the lifespan: a roadmap.

Péter S, Eggersdorfer M, van Asselt D, Buskens E, Detzel P, Freijer K, Koletzko B, Kraemer K, Kuipers F, Neufeld L, Obeid R, Wieser S, Zittermann A, Weber P.

Nutrients. 2014 Dec 22;6(12):6076-94. doi: 10.3390/nu6126076.

39.

Valuation of depression co-occurring with a somatic condition: feasibility of the time trade-off task.

Papageorgiou K, Vermeulen KM, Leijten FR, Buskens E, Ranchor AV, Schroevers MJ.

Health Expect. 2015 Dec;18(6):3147-59. doi: 10.1111/hex.12303. Epub 2014 Nov 13.

40.

Prediction of asymptomatic carotid artery stenosis in the general population: identification of high-risk groups.

de Weerd M, Greving JP, Hedblad B, Lorenz MW, Mathiesen EB, O'Leary DH, Rosvall M, Sitzer M, de Borst GJ, Buskens E, Bots ML.

Stroke. 2014 Aug;45(8):2366-71. doi: 10.1161/STROKEAHA.114.005145. Epub 2014 Jul 3.

41.

Improving acute stroke services in the Netherlands.

Lahr MM, van der Zee DJ, Luijckx GJ, Vroomen PC, Buskens E.

BMJ. 2014 Jun 24;348:g3957. doi: 10.1136/bmj.g3957. No abstract available.

PMID:
24962694
42.

Prehospital factors determining regional variation in thrombolytic therapy in acute ischemic stroke.

Lahr MM, Vroomen PC, Luijckx GJ, van der Zee DJ, de Vos R, Buskens E.

Int J Stroke. 2014 Oct;9 Suppl A100:31-5. doi: 10.1111/ijs.12236. Epub 2013 Dec 23.

PMID:
24373584
43.

Thrombolysis in acute ischemic stroke: a simulation study to improve pre- and in-hospital delays in community hospitals.

Lahr MM, van der Zee DJ, Vroomen PC, Luijckx GJ, Buskens E.

PLoS One. 2013 Nov 18;8(11):e79049. doi: 10.1371/journal.pone.0079049. eCollection 2013.

44.

A simulation-based approach for improving utilization of thrombolysis in acute brain infarction.

Lahr MM, van der Zee DJ, Luijckx GJ, Vroomen PC, Buskens E.

Med Care. 2013 Dec;51(12):1101-5. doi: 10.1097/MLR.0b013e3182a3e505.

PMID:
23938599
45.

Testing the McSad depression specific classification system in patients with somatic conditions: validity and performance.

Papageorgiou K, Vermeulen KM, Schroevers MJ, Buskens E, Ranchor AV.

Health Qual Life Outcomes. 2013 Jul 26;11:125. doi: 10.1186/1477-7525-11-125.

46.

A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions.

Postmus D, Tervonen T, van Valkenhoef G, Hillege HL, Buskens E.

Eur J Health Econ. 2014 Sep;15(7):709-16. doi: 10.1007/s10198-013-0517-9. Epub 2013 Jul 11.

PMID:
23843123
47.

Probability elicitation to inform early health economic evaluations of new medical technologies: a case study in heart failure disease management.

Cao Q, Postmus D, Hillege HL, Buskens E.

Value Health. 2013 Jun;16(4):529-35. doi: 10.1016/j.jval.2013.02.008. Epub 2013 May 6.

48.

Value of information analysis from a societal perspective: a case study in prevention of major depression.

Mohseninejad L, van Baal PH, van den Berg M, Buskens E, Feenstra T.

Value Health. 2013 Jun;16(4):490-7. doi: 10.1016/j.jval.2012.12.007. Epub 2013 Feb 20.

49.

The cost-utility of haemodiafiltration versus haemodialysis in the Convective Transport Study.

Mazairac AH, Blankestijn PJ, Grooteman MP, Penne EL, van der Weerd NC, den Hoedt CH, Buskens E, van den Dorpel MA, ter Wee PM, Nubé MJ, Bots ML, de Wit GA; CONTRAST investigators.

Nephrol Dial Transplant. 2013 Jul;28(7):1865-73. doi: 10.1093/ndt/gft045. Epub 2013 Jun 13.

PMID:
23766337
50.

Development and measurement properties of the self assessment version of the INTERMED for the elderly to assess case complexity.

Peters LL, Boter H, Slaets JP, Buskens E.

J Psychosom Res. 2013 Jun;74(6):518-22. doi: 10.1016/j.jpsychores.2013.02.003. Epub 2013 Mar 7.

PMID:
23731750

Supplemental Content

Loading ...
Support Center